106 related articles for article (PubMed ID: 9880547)
21. Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells.
Fukazawa T; Fujiwara T; Uno F; Teraishi F; Kadowaki Y; Itoshima T; Takata Y; Kagawa S; Roth JA; Tschopp J; Tanaka N
Oncogene; 2001 Aug; 20(37):5225-31. PubMed ID: 11526513
[TBL] [Abstract][Full Text] [Related]
22. Mimicry of bryostatin 1 induced phosphorylation patterns in HL-60 cells by high-phorbol ester concentrations.
Warren BS; Kamano Y; Pettit GR; Blumberg PM
Cancer Res; 1988 Nov; 48(21):5984-8. PubMed ID: 3167850
[TBL] [Abstract][Full Text] [Related]
23. Bryostatin, an activator of the calcium phospholipid-dependent protein kinase, blocks phorbol ester-induced differentiation of human promyelocytic leukemia cells HL-60.
Kraft AS; Smith JB; Berkow RL
Proc Natl Acad Sci U S A; 1986 Mar; 83(5):1334-8. PubMed ID: 3456591
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of PMA-induced human T cell proliferation by bryostatin is associated with enhanced degradation of conventional protein kinase C (cPKC): Ca2+ signals restore mitogenic activity without abrogating enhanced cPKC degradation.
Galron D; Tamir A; Altman A; Isakov N
Cell Immunol; 1994 Oct; 158(1):195-207. PubMed ID: 8087865
[TBL] [Abstract][Full Text] [Related]
25. mdm2 and bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway.
Chang YC; Lee YS; Tejima T; Tanaka K; Omura S; Heintz NH; Mitsui Y; Magae J
Cell Growth Differ; 1998 Jan; 9(1):79-84. PubMed ID: 9438391
[TBL] [Abstract][Full Text] [Related]
26. Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1.
Asher G; Lotem J; Sachs L; Kahana C; Shaul Y
Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13125-30. PubMed ID: 12232053
[TBL] [Abstract][Full Text] [Related]
27. Bryostatin 1 induces prolonged activation of extracellular regulated protein kinases in and apoptosis of LNCaP human prostate cancer cells overexpressing protein kinase calpha.
Gschwend JE; Fair WR; Powell CT
Mol Pharmacol; 2000 Jun; 57(6):1224-34. PubMed ID: 10825394
[TBL] [Abstract][Full Text] [Related]
28. In vivo ubiquitination and proteasome-mediated degradation of p53(1).
Maki CG; Huibregtse JM; Howley PM
Cancer Res; 1996 Jun; 56(11):2649-54. PubMed ID: 8653711
[TBL] [Abstract][Full Text] [Related]
29. beta-catenin is a target for the ubiquitin-proteasome pathway.
Aberle H; Bauer A; Stappert J; Kispert A; Kemler R
EMBO J; 1997 Jul; 16(13):3797-804. PubMed ID: 9233789
[TBL] [Abstract][Full Text] [Related]
30. Deoxycholic acid suppresses p53 by stimulating proteasome-mediated p53 protein degradation.
Qiao D; Gaitonde SV; Qi W; Martinez JD
Carcinogenesis; 2001 Jun; 22(6):957-64. PubMed ID: 11375905
[TBL] [Abstract][Full Text] [Related]
31. The stabilization mechanism of mutant-type p53 by impaired ubiquitination: the loss of wild-type p53 function and the hsp90 association.
Nagata Y; Anan T; Yoshida T; Mizukami T; Taya Y; Fujiwara T; Kato H; Saya H; Nakao M
Oncogene; 1999 Oct; 18(44):6037-49. PubMed ID: 10557093
[TBL] [Abstract][Full Text] [Related]
32. Modulation of protein kinase C activity and calcium-sensitive isoform expression in human myeloid leukemia cells by bryostatin 1: relationship to differentiation and ara-C-induced apoptosis.
Grant S; Turner AJ; Freemerman AJ; Wang Z; Kramer L; Jarvis WD
Exp Cell Res; 1996 Oct; 228(1):65-75. PubMed ID: 8892972
[TBL] [Abstract][Full Text] [Related]
33. Prostate carcinoma cell death resulting from inhibition of proteasome activity is independent of functional Bcl-2 and p53.
Herrmann JL; Briones F; Brisbay S; Logothetis CJ; McDonnell TJ
Oncogene; 1998 Dec; 17(22):2889-99. PubMed ID: 9879995
[TBL] [Abstract][Full Text] [Related]
34. Geldanamycin-stimulated destabilization of mutated p53 is mediated by the proteasome in vivo.
Whitesell L; Sutphin P; An WG; Schulte T; Blagosklonny MV; Neckers L
Oncogene; 1997 Jun; 14(23):2809-16. PubMed ID: 9190897
[TBL] [Abstract][Full Text] [Related]
35. Cyclopentenone prostaglandins of the J series inhibit the ubiquitin isopeptidase activity of the proteasome pathway.
Mullally JE; Moos PJ; Edes K; Fitzpatrick FA
J Biol Chem; 2001 Aug; 276(32):30366-73. PubMed ID: 11390388
[TBL] [Abstract][Full Text] [Related]
36. Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway.
Mehle A; Strack B; Ancuta P; Zhang C; McPike M; Gabuzda D
J Biol Chem; 2004 Feb; 279(9):7792-8. PubMed ID: 14672928
[TBL] [Abstract][Full Text] [Related]
37. B cell receptor-induced cAMP-response element-binding protein activation in B lymphocytes requires novel protein kinase Cdelta.
Blois JT; Mataraza JM; MecklenbraĆ¼ker I; Tarakhovsky A; Chiles TC
J Biol Chem; 2004 Jul; 279(29):30123-32. PubMed ID: 15138267
[TBL] [Abstract][Full Text] [Related]
38. Divergent effects of bryostatin 1 and phorbol myristate acetate on cell cycle arrest and maturation in human myelomonocytic leukemia cells (U937).
Vrana JA; Saunders AM; Chellappan SP; Grant S
Differentiation; 1998 May; 63(1):33-42. PubMed ID: 9615391
[TBL] [Abstract][Full Text] [Related]
39. Expression of mitogen-inducible cyclooxygenase induced by lipopolysaccharide: mediation through both mitogen-activated protein kinase and NF-kappaB signaling pathways in macrophages.
Hwang D; Jang BC; Yu G; Boudreau M
Biochem Pharmacol; 1997 Jul; 54(1):87-96. PubMed ID: 9296354
[TBL] [Abstract][Full Text] [Related]
40. Modulation of p53, WAF1/p21 and BCL-2 expression during retinoic acid-induced differentiation of NB4 promyelocytic cells.
Bocchia M; Xu Q; Wesley U; Xu Y; Korontsvit T; Loganzo F; Albino AP; Scheinberg DA
Leuk Res; 1997 May; 21(5):439-47. PubMed ID: 9225073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]